These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35996844)

  • 1. Methyltransferase like 3 enhances pinin mRNA stability through N
    He M; Jiang D; Xun A; Yang J; Luo Q; Wu H
    Exp Physiol; 2022 Nov; 107(11):1283-1297. PubMed ID: 35996844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M; Zhai X; Chen Y; Yin D
    Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression.
    Cui Y; Lv P; Zhang C
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23749. PubMed ID: 38800929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma.
    Zhang Y; Tian X; Bai Y; Liu X; Zhu J; Zhang L; Wang J
    Mamm Genome; 2022 Dec; 33(4):654-671. PubMed ID: 36173464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
    Xu J; Chen Q; Tian K; Liang R; Chen T; Gong A; Mathy NW; Yu T; Chen X
    Oncol Rep; 2020 Sep; 44(3):973-986. PubMed ID: 32705223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic effect of PNN in digestive tract cancers and its correlation with the tumor immune landscape in colon adenocarcinoma.
    Zhang H; Jin M; Ye M; Bei Y; Yang S; Liu K
    J Clin Lab Anal; 2022 Apr; 36(4):e24327. PubMed ID: 35257416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N
    Wang A; Zeng Y; Zhang W; Zhao J; Gao L; Li J; Zhu J; Liu Z; Huang JA
    Cell Mol Biol Lett; 2024 Aug; 29(1):106. PubMed ID: 39095708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3-mediated m
    Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
    Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis.
    Miao Z; Liu S; Xiao X; Li D
    Gene; 2020 Jun; 743():144604. PubMed ID: 32213297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway.
    Xing Y; Zhang Z; Chi F; Zhou Y; Ren S; Zhao Z; Zhu Y; Piao D
    Mol Carcinog; 2019 Oct; 58(10):1795-1808. PubMed ID: 31219650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
    Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
    Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-mediated downregulation of splicing factor SRSF11 is associated with carcinogenesis and poor survival of cancer patients.
    Oh J; Oh JM; Cho SY
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2561-2570. PubMed ID: 37013774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
    Xu D; Shao J; Song H; Wang J
    Biomed Res Int; 2020; 2020():9502560. PubMed ID: 32596399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of KIAA1429, a N6-methyladenine methyltransferase, inhibits the progression of colon adenocarcinoma via blocking the hypoxia-inducible factor 1 signalling pathway.
    Ouyang C; Xu G; Xie J; Xie Y; Zhou Y
    J Biochem Mol Toxicol; 2024 Sep; 38(9):e23829. PubMed ID: 39215765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
    Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X
    Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.